SIONNA THERAPEUTICS
Live / Applied — Statement of use — registration review complete (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 16 Jul 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90833921
- Mark type
- Stylized text
- Filed
- 16 Jul 2021
- Published for opposition
- 07 Jun 2022
- Attorney of record
- Keith Toms, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pulmonary diseases and rare diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- SIONNA THERAPEUTICS, INC., Waltham, MA, US
- Sling Therapeutics, Inc., Natick, MA, US
- Sling Therapeutics, Inc., Natick, MA, US
Prosecution history
- 01 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Mar 2026 — ASSIGNED TO LIE
- 26 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Nov 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 20 Nov 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 04 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Aug 2025 — NON-FINAL ACTION E-MAILED
- 26 Aug 2025 — SU - NON-FINAL ACTION - WRITTEN